findmyKOL
Clinical trialNCT02025036UnknownPhase 3Interventional

Chemoradiotherapy of Capecitabine With or Without Oxaliplatin Versus Cisplatin-5-FU for Esophageal Squamous Cancer

SponsorThe First Affiliated Hospital of Henan University of Science and TechnologyEnrollment249Stage III Esophageal Squamous Cell CarcinomaStage II Esophageal Squamous Cell Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Anping Zheng, M.D M.S

    Anyang Tumour Hospital of Henan province

    Principal Investigator
  • Dan Wang, M.D M.S

    The First Affiliated Hospital of Henan University of Science and Technology

    Principal Investigator
  • Dan Zhou, M.D M.S

    The First Affiliated Hospital of Henan University of Science and Technology

    Principal Investigator
  • Daoke Yang, M.D M.S

    The First Affiliated Hospital of Zhengzhou University

    Principal Investigator
  • Fuyou Zhou, M.D Ph.D

    Anyang Tumour Hospital of Henan province

    Principal Investigator
  • Guobao Zheng, M.D Ph.D

    No. 150 Central Hospital of the Chinese People Liberation Army

    Principal Investigator
  • Guoqiang Kong, M.D M.S

    The First Affiliated Hospital of Henan University of Science and Technology

    Principal Investigator
  • Jiachun Sun, M.D Ph.D

    The First Affiliated Hospital of Henan University of Science and Technology

    Principal Investigator
  • Jianhua Wang, M.D Ph.D

    Henan Tumor Hospital

    Principal Investigator
  • Jing Ren, M.D M.S

    The First Affiliated Hospital of Henan University of Science and Technology

    Principal Investigator
  • Nengchao Wang, M.D M.S

    Anyang Tumour Hospital of Henan province

    Principal Investigator
  • Ruina Yang, M.D M.S

    The First Affiliated Hospital of Henan University of Science and Technology

    Principal Investigator
  • Ruinuo Jia, M.D Ph.D

    The First Affiliated Hospital of Henan University of Science and Technology

    Principal Investigator
  • Ruiwen Zhang, M.D M.S

    Xinxiang Central Hospital of Henan province

    Principal Investigator
  • Shegan Gao, M.D Ph.D

    The First Affiliated Hospital of Henan University of Science and Technology

    Study Chair
  • Shiyuan Song, M.D M.S

    The First Affiliated Hospital of Henan University of Science and Technology

    Principal Investigator
  • Tanyou Shan, M.D M.S

    The First Affiliated Hospital of Henan University of Science and Technology

    Study Director
  • Wei Wang, M.D M.S

    The First Affiliated Hospital of Henan University of Science and Technology

    Principal Investigator
  • Weijiao Yin, M.D M.S

    The First Affiliated Hospital of Henan University of Science and Technology

    Principal Investigator
  • Xiaoshan Feng, M.D Ph.D

    The First Affiliated Hospital of Henan University of Science and Technology

    Study Director
  • Xiaozhi Yuan, M.D M.S

    The First Affiliated Hospital of Henan University of Science and Technology

    Principal Investigator
  • Xinshuai Wang, M.D Ph.D

    The First Affiliated Hospital of Henan University of Science and Technology

    Principal Investigator
  • Yali Zhang, M.D M.S

    The First Affiliated Hospital of Henan University of Science and Technology

    Principal Investigator
  • Yongxuan Liu, M.D M.S

    The First Affiliated Hospital of Henan University of Science and Technology

    Principal Investigator
  • Zhanhui Miao, M.D M.S

    Affiliated Hospital of Xinxiang Medical University, Henan province

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • the First Affiliated Hospital of Henan University of Science and Technology

    Luoyang, Henan, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2014
Primary completion
13 Sept 2022
Completion
1 Apr 2025
Last update posted
8 Feb 2023
Registered enrollment
249
Registry id
NCT02025036

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.